HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-MAY-15 5BRF TITLE CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI GLUCOKINASE IN COMPLEX WITH TITLE 2 INHIBITOR HPOP-GLCN COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE 1, PUTATIVE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TRYPANOSOMA CRUZI GLUCOKINASE; COMPND 5 EC: 2.7.1.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI (STRAIN CL BRENER); SOURCE 3 ORGANISM_TAXID: 353153; SOURCE 4 STRAIN: CL BRENER; SOURCE 5 GENE: TC00.1047053510187.100; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A(+) KEYWDS TRANSFERASE, HEXOSE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.L.D'ANTONIO,K.PERRY,M.S.DEINEMA,S.P.KEARNS,T.A.FREY REVDAT 8 27-SEP-23 5BRF 1 HETSYN REVDAT 7 29-JUL-20 5BRF 1 REMARK SITE ATOM REVDAT 6 25-DEC-19 5BRF 1 REMARK REVDAT 5 27-SEP-17 5BRF 1 JRNL REMARK REVDAT 4 10-FEB-16 5BRF 1 JRNL REVDAT 3 03-FEB-16 5BRF 1 JRNL REVDAT 2 23-DEC-15 5BRF 1 JRNL REVDAT 1 17-JUN-15 5BRF 0 JRNL AUTH E.L.D'ANTONIO,M.S.DEINEMA,S.P.KEARNS,T.A.FREY,S.TANGHE, JRNL AUTH 2 K.PERRY,T.A.ROY,H.S.GRACZ,A.RODRIGUEZ,J.D'ANTONIO JRNL TITL STRUCTURE-BASED APPROACH TO THE IDENTIFICATION OF A NOVEL JRNL TITL 2 GROUP OF SELECTIVE GLUCOSAMINE ANALOGUE INHIBITORS OF JRNL TITL 3 TRYPANOSOMA CRUZI GLUCOKINASE. JRNL REF MOL.BIOCHEM.PARASITOL. V. 204 64 2016 JRNL REFN ISSN 0166-6851 JRNL PMID 26778112 JRNL DOI 10.1016/J.MOLBIOPARA.2015.12.004 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 46407 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.4081 - 5.4028 0.98 2682 140 0.1641 0.2072 REMARK 3 2 5.4028 - 4.2892 0.99 2651 121 0.1602 0.1903 REMARK 3 3 4.2892 - 3.7472 1.00 2641 158 0.1713 0.1890 REMARK 3 4 3.7472 - 3.4047 0.98 2586 126 0.1864 0.2344 REMARK 3 5 3.4047 - 3.1607 0.99 2628 138 0.2062 0.2691 REMARK 3 6 3.1607 - 2.9744 0.99 2629 146 0.2147 0.2671 REMARK 3 7 2.9744 - 2.8255 0.99 2610 138 0.2127 0.2606 REMARK 3 8 2.8255 - 2.7025 0.98 2567 137 0.2178 0.2691 REMARK 3 9 2.7025 - 2.5985 0.99 2610 144 0.2235 0.3022 REMARK 3 10 2.5985 - 2.5088 0.99 2590 152 0.2223 0.3044 REMARK 3 11 2.5088 - 2.4303 0.99 2583 156 0.2141 0.2814 REMARK 3 12 2.4303 - 2.3609 0.99 2618 133 0.2224 0.2961 REMARK 3 13 2.3609 - 2.2987 0.98 2567 167 0.2239 0.3094 REMARK 3 14 2.2987 - 2.2426 0.97 2563 128 0.2259 0.2735 REMARK 3 15 2.2426 - 2.1917 0.98 2597 113 0.2271 0.2531 REMARK 3 16 2.1917 - 2.1450 0.98 2561 133 0.2312 0.2535 REMARK 3 17 2.1450 - 2.1020 0.90 2382 112 0.2386 0.3135 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5820 REMARK 3 ANGLE : 1.087 7868 REMARK 3 CHIRALITY : 0.074 866 REMARK 3 PLANARITY : 0.005 1022 REMARK 3 DIHEDRAL : 14.217 2170 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BRF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97920 REMARK 200 MONOCHROMATOR : CRYOGENICALLY-COOLED SINGLE REMARK 200 CRYSTAL SI(220) SIDE BOUNCE REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : LR-DESIGN DETECTOR POSITIONER REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46434 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.38900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2Q2R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: A GLUCOSE-FREE TCGLCK CRYSTAL WAS REMARK 280 SOAKED IN 1.0 MM HPOP-GLCN, 5.0% (V/V) DMSO, 0.1 M SODIUM REMARK 280 CITRATE (PH 7.0), 18% (W/V) PEG 3,350 FOR 24 HOURS, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.00800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 ARG A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 GLY A -2 REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 GLY A 43 REMARK 465 LYS A 44 REMARK 465 ASN A 45 REMARK 465 MET B -13 REMARK 465 GLY B -12 REMARK 465 ARG B -11 REMARK 465 GLY B -10 REMARK 465 SER B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 GLY B -2 REMARK 465 MET B -1 REMARK 465 ALA B 0 REMARK 465 GLY B 43 REMARK 465 LYS B 44 REMARK 465 ASN B 45 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP B 144 NH1 ARG B 361 2.03 REMARK 500 OD2 ASP A 61 OG1 THR A 63 2.10 REMARK 500 OE2 GLU A 150 NZ LYS A 350 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 92 45.07 -84.42 REMARK 500 ARG A 216 -101.52 -118.35 REMARK 500 SER A 240 176.07 176.31 REMARK 500 ARG A 253 74.60 34.41 REMARK 500 LEU B 75 45.26 -90.50 REMARK 500 PRO B 92 44.99 -83.98 REMARK 500 ALA B 99 -13.28 -158.25 REMARK 500 ARG B 216 -99.63 -120.48 REMARK 500 LEU B 352 129.37 -176.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q2R RELATED DB: PDB REMARK 900 2Q2R IS A SIMILAR PROTEIN; HOWEVER, IT HAS 8 DIFFERENT POINT REMARK 900 MUTATIONS. 2Q2R IS ALSO COMPLEXED WITH LIGANDS BETA-D-GLUCOSE AND REMARK 900 ADP. REMARK 900 RELATED ID: 5BRD RELATED DB: PDB REMARK 900 5BRD CONTAINS THE SAME PROTEIN COMPLEXED WITH BENZ-GLCN. REMARK 900 RELATED ID: 5BRE RELATED DB: PDB REMARK 900 5BRE CONTAINS THE SAME PROTEIN COMPLEXED WITH CBZ-GLCN. REMARK 900 RELATED ID: 5BRH RELATED DB: PDB DBREF 5BRF A 1 367 UNP Q4E4E1 Q4E4E1_TRYCC 1 367 DBREF 5BRF B 1 367 UNP Q4E4E1 Q4E4E1_TRYCC 1 367 SEQADV 5BRF MET A -13 UNP Q4E4E1 INITIATING METHIONINE SEQADV 5BRF GLY A -12 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF ARG A -11 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF GLY A -10 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF SER A -9 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -8 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -7 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -6 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -5 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -4 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS A -3 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF GLY A -2 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF MET A -1 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF ALA A 0 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF MET B -13 UNP Q4E4E1 INITIATING METHIONINE SEQADV 5BRF GLY B -12 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF ARG B -11 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF GLY B -10 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF SER B -9 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -8 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -7 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -6 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -5 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -4 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF HIS B -3 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF GLY B -2 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF MET B -1 UNP Q4E4E1 EXPRESSION TAG SEQADV 5BRF ALA B 0 UNP Q4E4E1 EXPRESSION TAG SEQRES 1 A 381 MET GLY ARG GLY SER HIS HIS HIS HIS HIS HIS GLY MET SEQRES 2 A 381 ALA MET ASN ILE LYS GLU LEU SER LEU HIS GLU LEU CYS SEQRES 3 A 381 GLU GLU LEU LYS THR PRO ALA TRP ASN VAL PRO LEU THR SEQRES 4 A 381 PHE VAL GLY ASP VAL GLY GLY THR SER ALA ARG MET GLY SEQRES 5 A 381 PHE VAL ARG GLU GLY LYS ASN ASP SER VAL HIS ALA CYS SEQRES 6 A 381 VAL THR ARG TYR SER MET LYS ARG LYS ASP ILE THR GLU SEQRES 7 A 381 LEU ILE GLU PHE PHE ASN GLU ILE ILE GLU LEU MET PRO SEQRES 8 A 381 ALA SER VAL ILE LYS ARG VAL LYS ALA GLY VAL ILE ASN SEQRES 9 A 381 VAL PRO GLY PRO VAL THR GLY GLY ALA VAL GLY GLY PRO SEQRES 10 A 381 PHE ASN ASN LEU LYS GLY ILE ALA ARG LEU SER ASP TYR SEQRES 11 A 381 PRO LYS ALA LEU PHE PRO PRO GLY ARG SER ALA ILE LEU SEQRES 12 A 381 ASN ASP LEU GLU ALA GLY GLY PHE GLY VAL LEU ALA VAL SEQRES 13 A 381 SER ASP ALA HIS VAL PHE SER GLU TYR PHE GLY VAL MET SEQRES 14 A 381 TRP GLU GLY THR GLN TRP ARG THR CYS GLU GLN GLU PRO SEQRES 15 A 381 ALA GLY SER VAL ILE GLY ARG GLY ARG CYS LEU VAL LEU SEQRES 16 A 381 ALA PRO GLY THR GLY LEU GLY SER SER LEU ILE TYR TYR SEQRES 17 A 381 ASN PRO MET ASN GLN GLN HIS ILE VAL VAL PRO LEU GLU SEQRES 18 A 381 LEU GLY SER GLN THR ILE PRO MET ARG LYS ASP ILE ASP SEQRES 19 A 381 TYR ILE GLN THR LEU HIS ALA GLU LEU LYS LEU LEU PRO SEQRES 20 A 381 ASN TYR GLU ASN MET VAL SER GLY ALA GLY LEU GLU PHE SEQRES 21 A 381 HIS TYR ARG GLN VAL VAL ARG GLY SER ARG PRO PRO CYS SEQRES 22 A 381 SER ALA GLY GLU ILE ALA LYS LEU ALA SER GLU GLY ASP SEQRES 23 A 381 ALA ASN ALA CYS LYS ALA MET LYS LYS TYR HIS GLU TYR SEQRES 24 A 381 LEU MET ARG VAL GLY SER GLU ALA SER MET ALA LEU LEU SEQRES 25 A 381 PRO LEU THR ILE VAL LEU VAL GLY ASP ASN ILE VAL ASN SEQRES 26 A 381 ASN ALA PHE PHE TYR ARG ASN PRO GLN ASN LEU LYS GLU SEQRES 27 A 381 MET HIS ARG GLU ALA LEU ASN HIS GLU MET GLU ARG PHE SEQRES 28 A 381 GLY PHE GLN SER ARG VAL THR TYR LEU ARG GLN LYS LYS SEQRES 29 A 381 LEU LEU ASN LEU ASN LEU MET GLY CYS TYR ARG CYS GLY SEQRES 30 A 381 LEU ASP LEU SER SEQRES 1 B 381 MET GLY ARG GLY SER HIS HIS HIS HIS HIS HIS GLY MET SEQRES 2 B 381 ALA MET ASN ILE LYS GLU LEU SER LEU HIS GLU LEU CYS SEQRES 3 B 381 GLU GLU LEU LYS THR PRO ALA TRP ASN VAL PRO LEU THR SEQRES 4 B 381 PHE VAL GLY ASP VAL GLY GLY THR SER ALA ARG MET GLY SEQRES 5 B 381 PHE VAL ARG GLU GLY LYS ASN ASP SER VAL HIS ALA CYS SEQRES 6 B 381 VAL THR ARG TYR SER MET LYS ARG LYS ASP ILE THR GLU SEQRES 7 B 381 LEU ILE GLU PHE PHE ASN GLU ILE ILE GLU LEU MET PRO SEQRES 8 B 381 ALA SER VAL ILE LYS ARG VAL LYS ALA GLY VAL ILE ASN SEQRES 9 B 381 VAL PRO GLY PRO VAL THR GLY GLY ALA VAL GLY GLY PRO SEQRES 10 B 381 PHE ASN ASN LEU LYS GLY ILE ALA ARG LEU SER ASP TYR SEQRES 11 B 381 PRO LYS ALA LEU PHE PRO PRO GLY ARG SER ALA ILE LEU SEQRES 12 B 381 ASN ASP LEU GLU ALA GLY GLY PHE GLY VAL LEU ALA VAL SEQRES 13 B 381 SER ASP ALA HIS VAL PHE SER GLU TYR PHE GLY VAL MET SEQRES 14 B 381 TRP GLU GLY THR GLN TRP ARG THR CYS GLU GLN GLU PRO SEQRES 15 B 381 ALA GLY SER VAL ILE GLY ARG GLY ARG CYS LEU VAL LEU SEQRES 16 B 381 ALA PRO GLY THR GLY LEU GLY SER SER LEU ILE TYR TYR SEQRES 17 B 381 ASN PRO MET ASN GLN GLN HIS ILE VAL VAL PRO LEU GLU SEQRES 18 B 381 LEU GLY SER GLN THR ILE PRO MET ARG LYS ASP ILE ASP SEQRES 19 B 381 TYR ILE GLN THR LEU HIS ALA GLU LEU LYS LEU LEU PRO SEQRES 20 B 381 ASN TYR GLU ASN MET VAL SER GLY ALA GLY LEU GLU PHE SEQRES 21 B 381 HIS TYR ARG GLN VAL VAL ARG GLY SER ARG PRO PRO CYS SEQRES 22 B 381 SER ALA GLY GLU ILE ALA LYS LEU ALA SER GLU GLY ASP SEQRES 23 B 381 ALA ASN ALA CYS LYS ALA MET LYS LYS TYR HIS GLU TYR SEQRES 24 B 381 LEU MET ARG VAL GLY SER GLU ALA SER MET ALA LEU LEU SEQRES 25 B 381 PRO LEU THR ILE VAL LEU VAL GLY ASP ASN ILE VAL ASN SEQRES 26 B 381 ASN ALA PHE PHE TYR ARG ASN PRO GLN ASN LEU LYS GLU SEQRES 27 B 381 MET HIS ARG GLU ALA LEU ASN HIS GLU MET GLU ARG PHE SEQRES 28 B 381 GLY PHE GLN SER ARG VAL THR TYR LEU ARG GLN LYS LYS SEQRES 29 B 381 LEU LEU ASN LEU ASN LEU MET GLY CYS TYR ARG CYS GLY SEQRES 30 B 381 LEU ASP LEU SER HET 4V5 A 500 23 HET 4V5 B 500 23 HETNAM 4V5 2-DEOXY-2-{[3-(4-HYDROXYPHENYL)PROPANOYL]AMINO}-ALPHA- HETNAM 2 4V5 D-GLUCOPYRANOSE HETSYN 4V5 N-[3-(4-HYDROXYPHENYL)PROPANOYL]-ALPHA-D-GLUCOSAMINE; HETSYN 2 4V5 2-DEOXY-2-{[3-(4-HYDROXYPHENYL)PROPANOYL]AMINO}-ALPHA- HETSYN 3 4V5 D-GLUCOSE; 2-DEOXY-2-{[3-(4-HYDROXYPHENYL) HETSYN 4 4V5 PROPANOYL]AMINO}-D-GLUCOSE; 2-DEOXY-2-{[3-(4- HETSYN 5 4V5 HYDROXYPHENYL)PROPANOYL]AMINO}-GLUCOSE FORMUL 3 4V5 2(C15 H21 N O7) FORMUL 5 HOH *244(H2 O) HELIX 1 AA1 SER A 7 LEU A 15 1 9 HELIX 2 AA2 LYS A 16 ASN A 21 5 6 HELIX 3 AA3 THR A 63 MET A 76 1 14 HELIX 4 AA4 PRO A 77 LYS A 82 1 6 HELIX 5 AA5 SER A 114 TYR A 116 5 3 HELIX 6 AA6 ASP A 131 ALA A 145 1 15 HELIX 7 AA7 VAL A 147 TYR A 151 1 5 HELIX 8 AA8 GLN A 160 GLU A 165 1 6 HELIX 9 AA9 GLU A 207 GLN A 211 5 5 HELIX 10 AB1 ASP A 218 LYS A 230 1 13 HELIX 11 AB2 ASN A 234 VAL A 239 1 6 HELIX 12 AB3 SER A 240 ARG A 253 1 14 HELIX 13 AB4 SER A 260 GLU A 270 1 11 HELIX 14 AB5 ASP A 272 LEU A 298 1 27 HELIX 15 AB6 GLY A 306 ASN A 312 1 7 HELIX 16 AB7 ASN A 312 ASN A 318 1 7 HELIX 17 AB8 ASN A 318 LEU A 330 1 13 HELIX 18 AB9 HIS A 332 GLY A 338 5 7 HELIX 19 AC1 PHE A 339 VAL A 343 5 5 HELIX 20 AC2 ASN A 353 SER A 367 1 15 HELIX 21 AC3 SER B 7 LEU B 15 1 9 HELIX 22 AC4 LYS B 16 ASN B 21 5 6 HELIX 23 AC5 THR B 63 LEU B 75 1 13 HELIX 24 AC6 VAL B 80 LYS B 82 5 3 HELIX 25 AC7 SER B 114 TYR B 116 5 3 HELIX 26 AC8 ASP B 131 ALA B 145 1 15 HELIX 27 AC9 VAL B 147 TYR B 151 1 5 HELIX 28 AD1 GLN B 160 GLU B 165 1 6 HELIX 29 AD2 GLU B 207 GLN B 211 5 5 HELIX 30 AD3 ASP B 218 LYS B 230 1 13 HELIX 31 AD4 ASN B 234 VAL B 239 1 6 HELIX 32 AD5 SER B 240 ARG B 253 1 14 HELIX 33 AD6 SER B 260 GLY B 271 1 12 HELIX 34 AD7 ASP B 272 LEU B 298 1 27 HELIX 35 AD8 GLY B 306 ASN B 312 1 7 HELIX 36 AD9 ASN B 312 ASN B 318 1 7 HELIX 37 AE1 ASN B 318 LEU B 330 1 13 HELIX 38 AE2 HIS B 332 GLY B 338 5 7 HELIX 39 AE3 ASN B 353 SER B 367 1 15 SHEET 1 AA1 6 ASN A 2 GLU A 5 0 SHEET 2 AA1 6 HIS A 49 SER A 56 1 O ALA A 50 N ASN A 2 SHEET 3 AA1 6 SER A 34 ARG A 41 -1 N ALA A 35 O TYR A 55 SHEET 4 AA1 6 LEU A 24 VAL A 30 -1 N ASP A 29 O ARG A 36 SHEET 5 AA1 6 VAL A 84 VAL A 91 1 O LYS A 85 N LEU A 24 SHEET 6 AA1 6 SER A 126 ASN A 130 1 O LEU A 129 N ILE A 89 SHEET 1 AA2 3 VAL A 95 THR A 96 0 SHEET 2 AA2 3 VAL A 100 GLY A 101 -1 O VAL A 100 N THR A 96 SHEET 3 AA2 3 ALA A 111 ARG A 112 -1 O ALA A 111 N GLY A 101 SHEET 1 AA3 6 PHE A 152 TRP A 156 0 SHEET 2 AA3 6 THR A 344 GLN A 348 -1 O TYR A 345 N MET A 155 SHEET 3 AA3 6 THR A 301 LEU A 304 1 N ILE A 302 O LEU A 346 SHEET 4 AA3 6 CYS A 178 PRO A 183 1 N LEU A 179 O THR A 301 SHEET 5 AA3 6 LEU A 187 ASN A 195 -1 O GLY A 188 N ALA A 182 SHEET 6 AA3 6 GLN A 200 LEU A 206 -1 O VAL A 204 N LEU A 191 SHEET 1 AA4 6 ASN B 2 LEU B 6 0 SHEET 2 AA4 6 HIS B 49 SER B 56 1 O VAL B 52 N LEU B 6 SHEET 3 AA4 6 SER B 34 ARG B 41 -1 N MET B 37 O THR B 53 SHEET 4 AA4 6 LEU B 24 VAL B 30 -1 N ASP B 29 O ARG B 36 SHEET 5 AA4 6 VAL B 84 VAL B 91 1 O VAL B 88 N PHE B 26 SHEET 6 AA4 6 SER B 126 ASN B 130 1 O LEU B 129 N ILE B 89 SHEET 1 AA5 3 VAL B 95 THR B 96 0 SHEET 2 AA5 3 VAL B 100 GLY B 101 -1 O VAL B 100 N THR B 96 SHEET 3 AA5 3 ALA B 111 ARG B 112 -1 O ALA B 111 N GLY B 101 SHEET 1 AA6 6 PHE B 152 TRP B 156 0 SHEET 2 AA6 6 THR B 344 GLN B 348 -1 O ARG B 347 N GLY B 153 SHEET 3 AA6 6 THR B 301 LEU B 304 1 N ILE B 302 O LEU B 346 SHEET 4 AA6 6 CYS B 178 PRO B 183 1 N LEU B 179 O THR B 301 SHEET 5 AA6 6 LEU B 187 ASN B 195 -1 O ILE B 192 N CYS B 178 SHEET 6 AA6 6 GLN B 200 LEU B 206 -1 O GLN B 200 N ASN B 195 CISPEP 1 GLY A 102 PRO A 103 0 2.72 CISPEP 2 GLY B 102 PRO B 103 0 4.99 CRYST1 68.114 80.016 75.797 90.00 95.05 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014681 0.000000 0.001296 0.00000 SCALE2 0.000000 0.012498 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013244 0.00000